|
|
 |
|
Vol. 2, No. 20, 11 October 2002
|
Other Issues:
|
 |
AIDScience Perspective:
Vaccine research:
Anti-R7V antibodies may protect some HIV-infected patients from developing AIDS: A conversation with Jean-Claude Chermann
[Full text article] [About AIDScience articles]
[See recent AIDScience articles]
[dEbates: Submit a response to this article]
|
Hot News:
Sexual behaviors in an urban bathhouse 15 years into the HIV epidemic. Well into the HIV epidemic, bathhouses remain venues for ongoing spread of HIV and opportunities for intervention.
Journal of Acquired Immune Deficiency Syndromes 30(5), 522, 2002 [Read abstract]
Related commentary the CDC HIV/STD/TB Prevention News Update:
[Read commentary]
|
Study: HIV clinics do not give consistent information on safe sex, HIV status disclosure to patients. HIV clinics differed substantially in the percentage of patients who reported that they received prevention messages from clinic staff.
AIDS 16(14), 1953, 27 September 2002 [Read abstract]
Related commentary from KaiserNetwork.org:
[Read commentary]
|
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. The small group of HIV-infected people who receive no treatment and yet show no signs of illness for years appear to have increased proliferative capacity of HIV-specific CD8+ T cells linked to enhanced effector function, than most clinical progressors who cannot control the virus.
Nature Immunology, published online 7 October 2002:
[Read abstract] (free registration required)
Related National Institute of Allergy and Infectious Diseases (NIAID) release:
[Read NIAID release]
|
Natural resistance to HIV: HIV-specific IgA is present in HIV-exposed, persistently seronegative (HEPS) individuals and neutralizes primary strains of HIV-1 in vitro. IgA exclusively bound an epitope within gp41 corresponding to the leucine zip motif in the alpha-helical region.
AIDS 16(13), 1731, 6 September 2002 [Read abstract]
Related article:
Journal of Acquired Immune Deficiency Syndromes 30(4), 413, 1 August 2002 [Read abstract]
|
Latest News Headlines:
[What is this?]
|
Lemon juice 'could stop AIDS'. BBC News. October 11, 2002
| South Africa may provide AIDS medicine. New York Times. October 11, 2002
| Optimism may work against HIV patients. Yahoo! News. October 11, 2002
| Vitamin intake affects mom-to-child HIV spread risk. Yahoo! News. October 11, 2002
| Study targets an HIV mystery. St. Paul Pioneer Press. October 11, 2002
| amfAR awards $760,000 for new research on HIV/AIDS. amfAR release. October 11, 2002
| Thailand's AIDS patients file suit. Newsday. October 10, 2002
| San Francisco: New city ad campaign shows HIV 'is no picnic'. San Francisco Chronicle. October 10, 2002
| New figures show AIDS fight under-resourced. UNAIDS release. October 10, 2002
| Viacom is planning a multimedia campaign against AIDS. New York Times. October 9, 2002
| Global war on AIDS runs short of key weapon. New York Times. October 9, 2002
| Battling back AIDS. Yahoo! News. October 8, 2002
| U.S. HHS awards $21.85 million to minority substance abuse/HIV prevention programs. SAMHSA release. October 8, 2002
| Global disease agency requests project funding. Boston Globe. October 7, 2002
| U.N. official warns Asia could face world's worst AIDS crisis. Yahoo! News. October 7, 2002
| Global Fund to Fight AIDS to begin distributing aid soon. Yahoo! News. October 7, 2002
| The sugar daddies' kiss of death. Washington Post. October 7, 2002
| AIDS seen spur to Africa famine. Boston Globe. October 7, 2002
| Gene experts win Nobel prize in medicine. New York Times. October 7, 2002
| South Africa plans to almost double AIDS spending. Yahoo! News. October 6, 2002
| Antibody region that blocks HIV identified. Yahoo! News. October 5, 2002
| Industry tackles AIDS drug scandal. BBC News. October 4, 2002
| AIDS vaccine developer VaxGen wins government anthrax contract. San Francisco Chronicle. October 4, 2002
| AIDS as a threat to global stability (opinion). New York Times. October 4, 2002
| HIV infection rates dropping in IV drug users. Yahoo! News. October 4, 2002
| Red Cross launches southern Africa AIDS campaign. Yahoo! News. October 3, 2002
| HIV drugs for poor found resold in Europe. Los Angeles Times. October 3, 2002
| Some patients to receive first batches of sterilized blood. Miami Herald. October 2, 2002
| AIDS activists win court battle against U.S. drug maker. San Francisco Chronicle. October 2, 2002
| Experts tell biotech companies the future looks bright for most. Newsday. October 2, 2002
| Condom shortage 'contributing to spread of AIDS in east Europe and Third World'. Financial Times. October 2, 2002
| In the shadow of AIDS, herpes is spreading. Newsday. October 1, 2002
| Once-a-day AIDS pill is in the works. Yahoo! News. October 1, 2002
| Report predicts AIDS epidemic for five nations. Boston Globe. October 1, 2002
| HIV groups: Bush fights prevention. Sun-Sentinel.com. October 1, 2002
| A nation facing disaster (editorial). New York Times. September 30, 2002
| Study: AIDS drug combats resistant virus strains. Yahoo! News. September 30, 2002
| Prison's rate of HIV frightens a nation. Philadelphia Inquirer. September 30, 2002
| Mystery anti-HIV factor unmasked?. Science News. September 30, 2002
| Rapid HIV tests near approval; restrictions on use debated. Miami Herald. September 29, 2002
| Official: Over half a million Cambodians to be AIDS victims by 2010. Yahoo! News. September 29, 2002
| Blood test to detect HIV in 20 minutes nears approval. Los Angeles Times. September 28, 2002
| Study shows concentrated AIDS drug is effective. Yahoo! News. September 28, 2002
|
|
More news headlines: This week | Last week | Search archive |
Latest Journal Headlines:
[What is this?]
|
| A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine. Vaccine. (Posted: October 11, 2002) | | Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness. Journal of Medical Primatology. (Posted: October 11, 2002) | | Characterization of CD4+T helper cell fine specificity to the envelope glycoproteins of SIH. Journal of Medical Primatology. (Posted: October 11, 2002) | | Protection by SIVVLP DNA prime/protein boost following mucosal SIV challenge. Journal of Medical Primatology. (Posted: October 11, 2002) | | NeuroAIDS: Magnetic resonance spectroscopy: an in vivo tool for monitoring cerebral injury in SIV. Journal of Medical Primatology. (Posted: October 11, 2002) | | Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies. Journal of Medical Primatology. (Posted: October 11, 2002) | | T cell receptor usage in patients with non-progressing HIV infection. Clinical and Experimental Immunology. (Posted: October 11, 2002) | | Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Research and Human Retroviruses. (Posted: October 11, 2002) | | HIV-1 transcription and virus production are induced by MRPs in human CD4(+) T lymphocytes. Journal of Immunology. (Posted: October 11, 2002) | | CD4 T cell depletion is linked directly to immune activation but only indirectly to the viral load. Journal of Immunology. (Posted: October 11, 2002) | | MHC class I alleles influence set-point viral load and survival time in SIV-infected rhesus monkeys. Journal of Immunology. (Posted: October 11, 2002) | | Cross-clade T lymphocyte-mediated immunity to HIV type 1. AIDS Research and Human Retroviruses. (Posted: October 11, 2002) | | Rhesus macaques that resist repeated intravaginal challenge with SIVmac251. AIDS Research and Human Retroviruses. (Posted: October 11, 2002) | | AIDS vaccines, immunology, and what we have learned. The AIDS Reader. (Posted: October 10, 2002) | | Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sexually Transmitted Infections. (Posted: October 10, 2002) | | HIV-specific CD8+ T cell proliferation is maintained in nonprogressors. Nature Immunology. (Posted: October 8, 2002) | | CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV. Journal of Immunology. (Posted: October 7, 2002) | | Associations between MHC class I and susceptibility to HIV-2 disease progression. Journal of Human Virology. (Posted: October 7, 2002) | | HIV-seropositive individuals' optimistic beliefs about prognosis. Journal of General Internal Medicine. (Posted: October 7, 2002) | | Development of vaccination strategies that elicit broadly neutralizing antibodies against HIV-1. Journal of Human Virology. (Posted: October 7, 2002) | | Temporal trends in the incidence of HIV infection and risk behavior among ID users. American Journal of Epidemiology. (Posted: October 4, 2002) | | Fetal feline immunodeficiency virus is prevalent and occult. The Journal of Infectious Diseases. (Posted: October 3, 2002) | | Determinants of mother-to-infant HIV-1 transmission before and after zidovudine prophylaxis. Archives of Pediatrics & Adolescent Medicine. (Posted: October 3, 2002) | | NeuroAIDS: Persistent SIV infection of a blood-brain barrier model. Journal of Neurovirology. (Posted: October 3, 2002) | | Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA. (Posted: October 3, 2002) | | NeuroAIDS: HIV-1-associated dementia: A basic science and clinical perspective. AIDS Reader. (Posted: October 2, 2002) | | Multiple subtypes of HIV-1 and HIV-2 are sensitive to a chemokine-receptor CXCR4 antagonist. Journal of Medical Virology. (Posted: October 1, 2002) | | Serum IgA of HIV-exposed uninfected individuals inhibit HIV. AIDS. (Posted: October 1, 2002) | | Risk behaviors and HIV incidence among repeat testers. Journal of Acquired Immune Deficiency Syndromes. (Posted: September 30, 2002) | | NeuroAIDS: Neuropathogenesis of lentiviral infection in macaques - Roles of CXCR4 and CCR5 viruses and IL-4. American Journal of Pathology. (Posted: September 29, 2002) | | Functional neutralization of Vif by intracellular immunization inhibits RT and viral replication. Journal of Biological Chemistry. (Posted: September 29, 2002) | | Contribution of human alpha-defensin-1, -2 and -3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. (Posted: September 29, 2002) |
|
More Journal articles: This month | Search archive |
|
|
|
